First Total Synthesis of (+)-Gelsedine

Total Page:16

File Type:pdf, Size:1020Kb

First Total Synthesis of (+)-Gelsedine UvA-DARE (Digital Academic Repository) First total synthesis of (+)-gelsedine Beyersbergen van Hen, W.G. Publication date 1999 Link to publication Citation for published version (APA): Beyersbergen van Hen, W. G. (1999). First total synthesis of (+)-gelsedine. General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl) Download date:01 Oct 2021 CHAPTER 1 INTRODUCTION 1.1 The Gelsemium Alkaloids The genus Gelsemium belongs to the plant family Loganiaceae and consists of three species, viz. Gelsemium elegans Benth., Gelsemium sempervirens Ait., and Gelsemium rankinii Small.1 G. elegans Benth. (in Chinese: Kou-Wen or Hu-Men-Teng) is distributed over southeastern Asia, and has been used in traditional Chinese medicine, as well as a remedy for certain kinds of skin ulcers, and more recently as an analgesic for the palliation of various acute cancer pains.lb G. sempervirens (yellow jasmine) is indigenous to southeastern United States and the highlands of central America. Although this plant causes death and abortion in livestock that feed upon its leaves, it has been used in the treatment of neuralgia and migraine, and spasmodic disorders such as asthma and whooping cough.1* The extracts of this plant are still sold by Vogel as a homeopathic medicine under the name of 'Gelsemium D6 drops' for the treatment of headaches and fever.2 G. rankinii Small also grows in southeastern United States. These three species have all been extensively investigated for the presence of alkaloids since more than a century. Scheme 1.1 /=\ HO Me 3 ((+)-gelsemine) OMe OMe OMe 4 ((+)-humentenine) 5 ((+)-gelselegirie) 6 ((-)-gelsedine) The alkaloids isolated from these plants have highly compact polycyclic structures and can be classified into six groups based on their skeletal types.la These are the sarpagine-, koumine-, gelsemine-, humentenine-, gelselegine-, and gelsedine-types. Examples of these Chapter 1 types of alkaloids are depicted in Scheme 1.1. The indole alkaloid koumidine (1) belongs to the sarpagine-type. The other five oxindole alkaloids bear the name of the type that they belong to. This thesis deals with the total synthesis of one of these structures, viz. gelsedine (6). Additional examples of the gelsedine-type of the Gelsemium alkaloids are depicted in Scheme 1.2.3The alkaloid gelsedine was isolated as a minor constituent from G sempervirens in 1953 by Schwarz and Marion4' and was later also found to occur in G. elegans.ih The structure of 6 was elucidated by Wenkert5 in 1962 on the basis of a spectroscopic comparison with the 11- methoxy analogue gelsemicine (7), which structure was already determined in 1961 through X- ray crystallography by Przybylska and Marion.6 Gelsedine and gelsemicine have, as can be expected from their structural resemblance, 25 comparable specific rotations [gelsedine: [a] D = -159 (c = 1.35, CHC13), m.p. 172.5-174 °C 25 and gelsemicine: [a] D = -142 (c = 0.95, CHC13), m.p. 171-172 °C], Although the biological activity of gelsedine has not been determined, gelsemicine is thought to constitute the active component in G. sempervirens, from which it was isolated in 1931.7 Gelsemicine proved to be far more toxic (MLD 0.05-0.06 mg/kg in rabbits, intravenous injection) than the principal alkaloid gelsemine (3) (MLD 180 mg/kg).lb OMe OMe OMe 6 ((-)-gelsedine, R = H) 8 (14-hydroxygelsedine, R = H) 10 (gelsenicine, R = H) 7 ((-)-gelsemicine, R = OMe) 9 (14-hydroxygelsemicine, R = OMe) 11 (14-hydroxygelsenicine, R = OH) More recently, the 14-hydroxy analogue of gelsedine (8)8 was isolated from both G. sempervirens and G. elegans. The alkaloids 14-hydroxygelsemicine (9)9, gelsenicine (10)10 and 14-hydroxygelsenicine (ll)10a11 were solely found in G. elegans. How these characteristic 14- hydroxy analogues evolve biogenetically is not yet known. Nevertheless, a tentative explanation for the biosynthesis of gelsedine is described in the next section. 1.2 Biogenetic Considerations Although the transformation of [6-I4C]-strictosidine into gelsemine in Gelsemium sempervirens with 0.47% incorporation has been reported, the exact biosynthetic pathway for 10 Introduction the Gelsemium alkaloids is still vague.12 It is envisioned that the biosynthesis starts with the condensation of tryptamine (12) and secologanin (13) followed by a Pictet-Spengler cyclization to give strictosidine (14) (Scheme 1.3).la Hydrolysis of the glycoside bond furnishes aldehyde 15. An intramolecular C-C bond formation between C-5 and C-16 in 15 would provide intermediate 16, the precursor for the sarpagine-type alkaloids, viz. koumidine (1). By C/D ring-cleavage and simultaneous ether linkage formation between C-3 and the primary alcohol at C-17 in 1, anhydrovobasinediol (17), also a sarpagine-alkaloid, would be generated. Scheme 1.3 OHC vOGIc NH2 W // + H" Me0 C ,£>Glc H 2 12 (tryptamine) 13 (secologanin) H Me02C 14 (strictosidine) O 17 (anhydrovobasinediol) 4 (humentenine) 6 (gelsedine) Subsequent enzymatic oxidation of anhydrovobasinediol (17) would first provide the humantenine-type oxindole alkaloids having the S-configuration at the C-7 spiro-center, viz. 4. Ring contraction of the six-membered ring through the elimination of the C-21 carbon would furnish the gelsedine-type alkaloids, viz. 6. The conversion from koumidine into gelsedine is illustrated in Section 1.4 by the biomimetic synthesis of gelselegine, gelsenicine and gelsedine by Sakai. 11 Chapter 1 1.3 Total Syntheses of Koumine and Gelsemine Total syntheses of Gelsemium alkaloids are of relatively recent date. In 1990, Magnus reported the first total synthesis of (+)-koumine.13 En route, the two related alkaloids (+)- koumidine14 and (+)-taberpsychine15 were also synthesized. All these synthetic alkaloids were antipodal to the natural compounds, although both antipodes were accessible. NMe NMe 3 ((+)-koumine) 1 ((+)-koumidine) 18 ((+)-taberpsychine) The biomimetic synthesis of (+)-koumine started from (S)-tryptophan, which was converted in four steps into N,N'-dibenzyltryptophan methyl ester 20 (Scheme 1.4). By using Cook's16 improvement of the Pictet-Spengler condensation 20 was treated with 2-ketoglutaric acid/benzene at reflux with provision for the removal of water. The resulting acids (67%) were esterified to give a mixture of diastereomeric methyl esters (ca. 2:1 in 80%). The major trans diastereomer 21 was isolated in 58% by fractional crystallization from methanol on a larger scale. The minor cis diastereomer could be isolated in pure form by chromatography of the mother liquors. The synthesis was continued with the more readily available trans diastereomer 21 to give eventually the antipodes of naturally occurring koumidine, taberpsychine and koumine. Scheme 1.4 ?X02H >C02Me H2OC^-"~-CO2H C02Me 4 steps 67%; W // NHBn NBn 62% N MeOH, Me3SiCl, Bn 58% 19 ((-)-tryptophan) 21 \^C02Me 22% 7 steps pyrrolidine, W // •£> TFA, 68% N N Bn C02Me Bn X. = C0 Me 23 22 2 First, 21 was transformed into the unsaturated acetylenic ester 22 in seven steps. Treatment of 22 with pyrrolidine and trifluoroacetic acid in benzene at reflux gave a mixture 12 Introduction of E- and Z-quinuclidines by reaction of the intermediate enamine with the a,ß-unsaturated acetylenic ester. The minor Z-isomer (12%) was converted into (+)-koumidine in five steps. The major E-isomer 23 (68%) was transformed into allylic alcohol 24 in four steps (Scheme 1.5). At this stage (+)-taberpsychine was synthesized in three steps from intermediate 24. (+)-Koumine was also synthesized from 24 by applying the sequence described in Scheme 1.5. Fragmentation of 24 by treatment with methyl chloroformate in CH2C12 gave methyl carbamate 26, presumably via the extended iminium ion 25. Reduction with LiAlH4 in THF furnished (+)-18-hydroxy-taberpsychine 27, which is not, as yet, a natural product. When 27 was exposed to Mitsunobu conditions (diethyl azodicarboxylate/Ph3P/imidazole/NaH in THF at reflux) it was converted into (+)-koumine (3) in an intramolecular SN2' reaction. A total number of 21 steps was needed starting from (S)-tryptophan and the overall yield was 0.18%. Scheme 1.5 4 steps 31% * C02Me 61% Me02CCl NMe DEAD, Ph3P NaH, 34% ,vH OH C02Me 3 ((+)-koumine) 26 R C 25 LiAlH4,78/o|-TiAlH 78°/ r ( = °2Me . ) 27 7fR=(R =M Me) The second Gelsemium alkaloid to be synthesized via total synthesis was gelsemine. Three syntheses were reported in 1994 by our17 and other groups18 and later other total syntheses of gelsemine were completed by Fukuyama19" and Overman.I9b However, no enantioselective synthesis has appeared to date. The synthesis of our group will be detailed here since it was one of the first to appear (Scheme 1.6). The synthesis started with a Diels-Alder reaction of E-hex-3,5-dien-l-ol20 28 with N- methylmaleimide 29 affording selectively the endo-adduct, imide 30, in excellent yield. Then 30 was converted in five steps into ethoxylactam 31 (E:Z 3:1).21 Subsequent subjection of 31 to BF,OEt, resulted in a highly stereospecific N-acyliminium ion cyclization via intermediate 32 to give aldehyde 33 as a separable 3:1 mixture of isomers at C-5.
Recommended publications
  • Rhazya Stricta S
    IENCE SC • VTT VTT S CIENCE • T S E Alkaloids of in vitro cultures of N C O H I N Rhazya stricta S O I V Dis s e r ta tion L • O S 93 G Rhazya stricta Decne. (Apocynaceae) is a traditional medicinal T Y H • R plant in Middle East and South Asia. It contains a large number of G I E L S H 93 E G terpenoid indole alkaloids (TIAs), some of which possess A I R H C interesting pharmacological properties. This study was focused on H biotechnological production tools of R. stricta, namely undifferentiated cell cultures, and an Agrobacterium rhizogenes- mediated transformation method to obtain hairy roots expressing heterologous genes from the early TIA pathway. Rha zya alkaloids comprise a wide range of structures and polarities, therefore, many A analytical methods were developed to investigate the alkaloid l k contents in in vitro cultures. Targeted and non-targeted analyses a l o were carried out using gas chromatography-mass spectrometry i d (GC-MS), high performance liquid chromatography (HPLC), ultra s o performance liquid chromatography-mass spectrometry (UPLC- f i MS) and nuclear magnetic resonance (NMR) spectroscopy. n Calli derived from stems contained elevated levels of v i t r strictosidine lactam compared to other in vitro cultures. It o was revealed that only leaves were susceptible to Agrobacterium c u infection and subsequent root induction. The transformation l t u efficiency varied from 22% to 83% depending on the gene. A total r e of 17 TIAs were identified from hairy root extracts by UPLC-MS.
    [Show full text]
  • A Review on Tabernaemontana Spp.: Multipotential Medicinal Plant
    Online - 2455-3891 Vol 11, Issue 5, 2018 Print - 0974-2441 Review Article A REVIEW ON TABERNAEMONTANA SPP.: MULTIPOTENTIAL MEDICINAL PLANT ANAN ATHIPORNCHAI* Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Burapha University, Bangsaen, Chonburi 20131 Thailand. Email: [email protected] Received: 01 March 2016, Revised and Accepted: 29 January 2018 ABSTRACT Plants in the genus Tabernaemontana have been using in Thai and Chinese traditional medicine for the treatment several diseases. The great majority constituents of Tabernaemontana species have already been subjected to isolation and identification of monoterpene indole alkaloids present in their several parts. Many of monoterpene indole alkaloids exhibited a wide array of several activities. The biogenesis, classification, and biological activities of these alkaloids which found in Tabernaemontana plants were discussed in this review and its brings the research up-to-date on the bioactive compounds produced by Tabernaemontana species, directly or indirectly related to human health. Keywords: Tabernaemontana plants, Phytochemistry, Biogenesis, Terpene indole alkaloids, Biological activities. © 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i5.11478 INTRODUCTION alkaloids are investigated. All monoterpene indole alkaloids are derived from aromatic amino acid tryptophan and the iridoid terpene Several already drugs were discovered from the natural products. secologanin (Scheme 1). Tryptophan converts to tryptamine using Especially, the treatments of infectious diseases and oncology have tryptophan decarboxylase which is a pyridoxal-dependent enzyme. benefited from numerous drugs which were found in natural product The specific iridoid precursor was subsequently identified as sources.
    [Show full text]
  • J.C.S. Perkin I
    2308 J.C.S. Perkin I The Biosynthesis of Monoterpenoid lndole Alkaloids from Strictosidine By Naotaka Nagakura, (Mrs.) Martin8 Ruffer, and Meinhart H. Zenk," Lehrstuhl fur Pflanzenphysiologie, Ruhr-Universitat Bochum, D 4630 Bochum, W. Germany The differential incorporation of doubly labelled strictosidine and vincoside into several indole alkaloids belonging to the Corynanthe (3a and 3p series), Aspidosperma, and lboga types in three plant families has been studied, and it has been demonstrated that only strictosidine is incorporated while vincoside is metabolically inert in these plants with regard to alkaloid formation. During the conversion of strictosidine into the 3P-indole alkaloids, the hydrogen atom at the 3-position is lost, while it is retained during the biosynthesis of the 32 alkaloids. The chemical synthesis of [7-3H]secologanin, an important intermediate for further work in the biosynthesis of monoterpenoid alkaloids, is also described. THEfundamental research of Battersby and Arigoni and (S)-3a stereochemistry, is indeed the key intermediate their associates during the past decade has established in the formation of the three classes of monoterpenoid the central role of loganin and secologanin (2) in the indole alkaloids (Asfiidosfierma, Iboga, and Corynanthe) biosynthesis of a multitude of monoterpenoid indole in Catharanthus roseus (syn. Vinca rosea) plants as well alkaloids. Secologanin (2) is the ultimate precursor for as a variety of other species in cell cultures by in vivo the C-9/C-10 non-tryptamine carbon skeleton
    [Show full text]
  • Biosynthesis by in Situ Hybridization (ISH)
    Localization of monoterpenoid indole alkaloid (MIA) biosynthesis by in situ hybridization (ISH) By Elizabeth Edmunds, Hons. B.Sc. A Thesis Submitted to the Department of Biotechnology In partial fulfillment of the requirements For the degree of Masters of Science August, 2012 Brock University St. Catha rines, Ontario ©Elizabeth Edmunds, 2012 ii Acknowledgments First and foremost I would like to thank Dr. Vincenzo Deluca for the opportunity to work in his laboratory under his mentorship. I have appreciated the helpful insight that has guided me through the course of this project. I have gained a valuable experience being able to learn from such an established and knowledgeable researcher. Secondly, I would like to thank my committee members Dr. Jeffrey Atkinson and Dr. Heather Gordon for their support and advice and their time to serve on my advisory committee. Thirdly, I would like to thank my colleagues and co-workers for their patience and helpful advice throughout my project. Particular mention must be given to Dr. Carlone's lab for their assistance and insight into in situ hybridization techniques. Finally, I would like to express my sincerest gratitude and appreciation towards my family and friends for their support. I would not be where I am today without the support and love from my mother and father, as well as Craig Easton. iii Abstract Monoterpenoid indole alkaloids (MIA) are among the largest and most complex group of nitrogen containing secondary metabolites that are characteristic of the Apocynaceae plant family including the most notable Catharanthus roseus. These compounds have demonstrated activity as successful drugs for treating various cancers, neurological disorders and cardiovascular conditions.
    [Show full text]
  • Deploying Microbial Synthesis for Halogenating and Diversifying Medicinal Alkaloid Scaffolds
    Downloaded from orbit.dtu.dk on: Sep 28, 2021 Deploying Microbial Synthesis for Halogenating and Diversifying Medicinal Alkaloid Scaffolds Bradley, Samuel Alan; Zhang, Jie; Jensen, Michael Krogh Published in: Frontiers in Bioengineering and Biotechnology Link to article, DOI: 10.3389/fbioe.2020.594126 Publication date: 2020 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Bradley, S. A., Zhang, J., & Jensen, M. K. (2020). Deploying Microbial Synthesis for Halogenating and Diversifying Medicinal Alkaloid Scaffolds. Frontiers in Bioengineering and Biotechnology, 8, [594126]. https://doi.org/10.3389/fbioe.2020.594126 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. fbioe-08-594126 October 19, 2020 Time: 19:15 # 1 REVIEW published: 23 October 2020 doi: 10.3389/fbioe.2020.594126 Deploying Microbial Synthesis for Halogenating and Diversifying Medicinal Alkaloid Scaffolds Samuel A. Bradley, Jie Zhang and Michael K.
    [Show full text]
  • Unlocking the Diversity of Alkaloids in Catharanthus Roseus: Nuclear Localization Suggests Metabolic Channeling in Secondary Metabolism
    Brief Communication Unlocking the Diversity of Alkaloids in Catharanthus roseus: Nuclear Localization Suggests Metabolic Channeling in Secondary Metabolism Graphical Abstract Authors Anna Stavrinides, Evangelos C. Tatsis, ..., Vincent Courdavault, Sarah E. O’Connor Correspondence [email protected] (S.E.O.), [email protected] (V.C.) In Brief How plants transform the central biosynthetic intermediate strictosidine into thousands of divergent alkaloids has remained unresolved. Stavrinides et al. discover a nuclear-localized alcohol dehydrogenase homolog responsible for conversion of strictosidine aglycone to tetrahydroalstonine that appears to interact with an upstream pathway enzyme. Highlights d Tetrahydroalstonine synthase catalyzes the formation of a plant-derived alkaloid d Tetrahydroalstonine synthase is localized to the nucleus d Tetrahydroalstonine synthase and the preceding pathway enzyme interact d Discovery of a gene controlling structural diversity of monoterpene indole alkaloids Stavrinides et al., 2015, Chemistry & Biology 22, 336–341 March 19, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.chembiol.2015.02.006 Chemistry & Biology Brief Communication Unlocking the Diversity of Alkaloids in Catharanthus roseus: Nuclear Localization Suggests Metabolic Channeling in Secondary Metabolism Anna Stavrinides,1 Evangelos C. Tatsis,1 Emilien Foureau,2 Lorenzo Caputi,1 Franziska Kellner,1 Vincent Courdavault,2,* and Sarah E. O’Connor1,* 1Department of Biological Chemistry, The John Innes Centre, Colney, Norwich NR4 7UH, UK 2Universite´ Franc¸ ois Rabelais de Tours, EA2106 ‘‘Biomole´ cules et Biotechnologies Ve´ ge´ tales’’, 37200 Tours, France *Correspondence: [email protected] (S.E.O.), [email protected] (V.C.) http://dx.doi.org/10.1016/j.chembiol.2015.02.006 This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
    [Show full text]
  • Fifty Years of Alkaloid Biosynthesis in Phytochemistry Q ⇑ Geoffrey A
    Phytochemistry 91 (2013) 29–51 Contents lists available at SciVerse ScienceDirect Phytochemistry journal homepage: www.elsevier.com/locate/phytochem Review Fifty years of alkaloid biosynthesis in Phytochemistry q ⇑ Geoffrey A. Cordell Natural Products Inc., Evanston, IL, USA Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA article info abstract Article history: An overview is presented of the studies related to the biosynthesis of alkaloids published in Phytochem- Available online 20 June 2012 istry in the past 50 years. Ó 2012 Elsevier Ltd. All rights reserved. Keywords: Alkaloids Biosynthesis Overview Contents 1. Introduction . ....................................................................................................... 30 1.1. Ornithine-derived alkaloids . .......................................................................... 30 1.2. Nicotine . .......................................................................................... 31 1.3. Tropane alkaloids . .......................................................................................... 33 1.4. Calystegines . .......................................................................................... 34 1.5. Pyrrolizidine alkaloids. .......................................................................................... 34 1.6. Retronecine . .......................................................................................... 34 1.7. Lysine-derived alkaloids . .........................................................................................
    [Show full text]
  • Solution of the Multistep Pathway for Assembly of Corynanthean, Strychnos, Iboga, and Aspidosperma Monoterpenoid Indole Alkaloids from 19E-Geissoschizine
    Solution of the multistep pathway for assembly of corynanthean, strychnos, iboga, and aspidosperma monoterpenoid indole alkaloids from 19E-geissoschizine Yang Qua, Michael E. A. M. Eassona,1, Razvan Simionescub, Josef Hajicekb,2, Antje M. K. Thamma,3, Vonny Salima,4, and Vincenzo De Lucaa,5 aDepartment of Biological Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada; and bDepartment of Chemistry, Brock University, St. Catharines, ON L2S 3A1, Canada Edited by Jerrold Meinwald, Cornell University, Ithaca, NY, and approved February 11, 2018 (received for review November 16, 2017) Monoterpenoid indole alkaloids (MIAs) possess a diversity of for the formation of tabersonine or catharanthine from 19E- alkaloid skeletons whose biosynthesis is poorly understood. A geissoschizine. Gene discovery involved a combination of bio- bioinformatic search of candidate genes, combined with their informatics and virus-induced gene silencing (VIGS) to identify virus-induced gene silencing, targeted MIA profiling and in vitro/ candidate genes and functional expression of the selected genes in vivo pathway reconstitution identified and functionally charac- by in vitro/in vivo reconstitution of the pathway. A series of terized six genes as well as a seventh enzyme reaction required for highly unstable intermediates that rearrange to other important the conversion of 19E-geissoschizine to tabersonine and catharan- MIA precursors when not used by appropriate enzymes reveals thine. The involvement of pathway intermediates in the formation the plasticity of MIA formation and how this fundamental of four MIA skeletons is described, and the role of stemmadenine- property led to diverse MIA structures found in nature. O-acetylation in providing necessary reactive substrates for the formation of iboga and aspidosperma MIAs is described.
    [Show full text]
  • De Novo Production of the Plant-Derived Alkaloid Strictosidine in Yeast
    De novo production of the plant-derived alkaloid strictosidine in yeast Stephanie Browna, Marc Clastreb, Vincent Courdavaultb, and Sarah E. O’Connora,1 aDepartment of Biological Chemistry, John Innes Centre, Norwich NR4 7UH, United Kingdom; and bÉquipe d’Accueil EA2106, “Biomolécules et Biotechnologies Végétales,” Université François-Rabelais de Tours, 37200 Tours, France Edited by Jerrold Meinwald, Cornell University, Ithaca, NY, and approved January 13, 2015 (received for review December 9, 2014) The monoterpene indole alkaloids are a large group of plant-derived abundance of available genetic tools for these organisms (21, 22). specialized metabolites, many of which have valuable pharmaceuti- We chose to use S. cerevisiae as a host because functional ex- cal or biological activity. There are ∼3,000 monoterpene indole alka- pression of microsomal plant P450s has more precedence in yeast loids produced by thousands of plant species in numerous families. (23). Additionally, plants exhibit extensive intracellular compart- The diverse chemical structures found in this metabolite class origi- mentalization of their metabolic pathways (24), and the impact nate from strictosidine, which is the last common biosynthetic inter- that this compartmentalization has on alkaloid biosynthesis can mediate for all monoterpene indole alkaloid enzymatic pathways. only be explored further in a eukaryotic host (25). To enhance Reconstitution of biosynthetic pathways in a heterologous host is genetic stability, we used homologous recombination to integrate a promising strategy for rapid and inexpensive production of com- the necessary biosynthetic genes under the control of strong plex molecules that are found in plants. Here, we demonstrate how constitutive promoters (TDH3, ADH1, TEF1, PGK1, TPI1)into strictosidine can be produced de novo in a Saccharomyces cerevisiae the S.
    [Show full text]
  • Exploring Anti-Hyperglycemic Potential of Alkaloid Compounds from Catharanthus Roseus G
    WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Ly et al. World Journal of Pharmacy and Pharmaceutical Sciences SJIF Impact Factor 6.647 Volume 6, Issue 8, 82-110 Research Article ISSN 2278 – 4357 EXPLORING ANTI-HYPERGLYCEMIC POTENTIAL OF ALKALOID COMPOUNDS FROM CATHARANTHUS ROSEUS G. DON (L) AGAINST VARIOUS TYPE II DIABETES TARGETS BY IN SILICO VIRTUAL SCREENING Thanh-Hoang Nguyen-Vo1,2, Dat Nguyen1, Phuc H. Le1 and Ly Le1* 1School of Biotechnology, International University - VNU, HCMC, Vietnam. 2Institute for Computational Science, Ton Duc Thang University, HCMC, Vietnam. GRAPHICAL ABSTRACT Article Received on 31 May 2017, Revised on 20 June 2017, Accepted on 11 July 2017 DOI: 10.20959/wjpps20178-9647 *Corresponding Author Ly Le School of Biotechnology, International University - VNU, HCMC, Vietnam. ABSTRACT Background: Catharanthus roseus (L.) G. Don (C. roseus) is a prominent anticancer herb having high alkaloid content. Besides known anticancer effect, this plant has been also traditionally used as an effective anti-diabetic treatment in many Asian countries, such as India, Malaysia, and Vietnam. Some in vivo and in vitro studies on its compounds and fractional extracts have confirmed its strong anti-hyperglycemia. This fact raises a question whether alkaloid compounds probably play any function in inhibitory activity on proteins related to Type 2 Diabetes Mellitus (T2DM). This study, therefore, was conducted not only to assess the role of alkaloid compounds in glucoregulatory pathway but also investigate other chemical groups treating T2DM besides known ones such as polyphenols and terpenoids. Objective: The study aims to calculate the binding affinity of alkaloids compounds of C. roseus toward four target proteins including 11β-HSD1, PTP1B, α-glucosidase and DPPIV www.wjpps.com Vol 6, Issue 8, 2017.
    [Show full text]
  • Rigorous Biogenetic Network for a Group of Indole Alkaloids Derived from Strictosidine†
    Molecules 2008, 13, 1875-1896; DOI: 10.3390/molecules13081875 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.org/molecules Review Rigorous Biogenetic Network for a Group of Indole Alkaloids † Derived from Strictosidine László F. Szabó Department of Organic Chemistry, Semmelweis University, Hőgyes utca 7, H-1092 Budapest, Hungary; E-mail: [email protected] † Chemotaxonomy of Indole Alkaloids, Part 5 (for Part 4, see [15]). This paper is dedicated to Prof. Heinz G. O. Becker on the occasion of his 85th birthday. Received: 5 August 2008; in revised form: 24 August 2008 / Accepted: 26 August 2008 / Published: 27 August 2008 Abstract: Strictosidine, the precursor of more than 2,500 indole alkaloids, was isolated from four species of three plant families. By searching the Dictionary of Natural Products on DVD it was found that about 150 indole alkaloids were obtained from the same species (coalkaloids), which is a direct proof of their common origin. On the base of their three- dimensional structure, taxonomic properties and standard reaction mechanisms an extended network was established which involved the four fundamental skeletons, the three types of carbon framework in the secologanin subunit and all major groups of indole alkaloids derived from secologanin and tryptamine (except a few minor groups, in which only less then 10 alkaloids were known). The system was extended to the heterodimer indole alkaloids and the quinoindole alkaloids as well. Keywords: Secologanin, coalkaloid, dimer alkaloid, reaction mechanism, computer searching, chemotaxonomy. Introduction The monoterpenoid indole alkaloids form a uniform group of natural products. Several generations of researchers have worked on their isolation, structure determination, chemical transformations and synthesis.
    [Show full text]
  • Introduction (Pdf)
    Dictionary of Natural Products on CD-ROM This introduction screen gives access to (a) a general introduction to the scope and content of DNP on CD-ROM, followed by (b) an extensive review of the different types of natural product and the way in which they are organised and categorised in DNP. You may access the section of your choice by clicking on the appropriate line below, or you may scroll through the text forwards or backwards from any point. Introduction to the DNP database page 3 Data presentation and organisation 3 Derivatives and variants 3 Chemical names and synonyms 4 CAS Registry Numbers 6 Diagrams 7 Stereochemical conventions 7 Molecular formula and molecular weight 8 Source 9 Importance/use 9 Type of Compound 9 Physical Data 9 Hazard and toxicity information 10 Bibliographic References 11 Journal abbreviations 12 Entry under review 12 Description of Natural Product Structures 13 Aliphatic natural products 15 Semiochemicals 15 Lipids 22 Polyketides 29 Carbohydrates 35 Oxygen heterocycles 44 Simple aromatic natural products 45 Benzofuranoids 48 Benzopyranoids 49 1 Flavonoids page 51 Tannins 60 Lignans 64 Polycyclic aromatic natural products 68 Terpenoids 72 Monoterpenoids 73 Sesquiterpenoids 77 Diterpenoids 101 Sesterterpenoids 118 Triterpenoids 121 Tetraterpenoids 131 Miscellaneous terpenoids 133 Meroterpenoids 133 Steroids 135 The sterols 140 Aminoacids and peptides 148 Aminoacids 148 Peptides 150 β-Lactams 151 Glycopeptides 153 Alkaloids 154 Alkaloids derived from ornithine 154 Alkaloids derived from lysine 156 Alkaloids
    [Show full text]